Vitamin K2 (MK-7 vs MK-4) and arterial calcification

What 3 graded rows on vitamin k2 (mk-7 vs mk-4) agree on for arterial calcification, and where they differ. Counted side by side, never averaged.

What the rows agree on

Each block and row is one graded row from the Vitamin K2 (MK-7 vs MK-4) page, with its PubMed record.

Your question

Vitamin K2 (MK-7 vs MK-4) and arterial calcification

3 rows · 592 people

Mostly no difference: 2 of 3 rows, and most of the people. 1 found an improvement.

No difference
Improved
Each block is one evidence row, sized by how many people it enrolled, with its grade inside.
  • Grade C× 1
  • Grade D× 1
  • No effect× 1
Rows
3
Trials
3
People
592

Where they differ

From the rows
Who was studiedWhen publishedGrade

The best-graded row, grade C, is a randomized trial of 167 people (2026) and found an improvement. 1 row is graded No effect, our grade for adequately powered trials that found no effect.

Only the 2 rows that found no difference name men and older adults in their population.

The row that found an improvement is newer (2026) than the 2 rows that found no difference (2019 to 2022).

The best grade is C among the row that found an improvement, and D among the rows that found no difference.

The rows

1 improved · 2 no difference
  1. Grade DFemoral artery calcification in type 2 diabetes with MK-7 · No difference

    RCT · n 60 · 2019 · Adults with type 2 diabetes and cardiovascular disease (the Netherlands; 68 randomised)

    360 mcg/day · 6 months

    Calcification on CT did not change versus placebo; active calcification on PET scans tended to increase with MK-7 (P = 0.06, not significant). dp-ucMGP fell. No adverse events.

    Row on the Vitamin K2 (MK-7 vs MK-4) page · PubMed 31387121 (opens PubMed)

  2. No effectAortic valve calcification with MK-7 plus vitamin D · No difference

    RCT · n 365 · 2022 · Older men with aortic valve calcification (AVADEC, Denmark)

    720 mcg/day MK-7 plus 25 mcg vitamin D · 24 months

    Valve calcification rose by 275 vs 292 units (difference not significant, P = 0.64); valve area, jet velocity, aortic and coronary calcification, valve surgery, deaths and cardiovascular events did not differ. dp-ucMGP fell with treatment.

    Row on the Vitamin K2 (MK-7 vs MK-4) page · PubMed 35465686 (opens PubMed)

  3. Grade CCoronary artery calcium progression with MK-7 in coronary artery disease · Improved

    RCT · n 167 · 2026 · Adults with symptomatic coronary artery disease and a calcium score of 50 to 400 (VitaK-CAC, the Netherlands; 180 randomised)

    360 mcg/day · 2 years

    Calcium scores rose from a median of 145 to 214 on placebo and from 135 to 184 on MK-7 (between-group P = .02); calcium mass showed the same pattern. No significant adverse effects.

    Row on the Vitamin K2 (MK-7 vs MK-4) page · PubMed 42268593 (opens PubMed)

Educational only. Not medical advice. Some links earn us a commission: kymatahealth.com/affiliate-disclosure.